GAMA
IONS icon

Graticule Asia Macro Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Graticule Asia Macro Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-100,000
Closed -$5.65M – 196
2020
Q4 		$5.65M Buy
+100,000
New +$4.98M 2.71% 8

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Graticule Asia Macro Advisors's IONS Position: Q1 2021 in Review

Graticule Asia Macro Advisors sold out of Ionis Pharmaceuticals (IONS) in Q1 2021, closing a stake of 100,000 shares — an estimated $5.65M sold.

Graticule Asia Macro Advisors first reported a position in IONS in Q4 2020 and held it in 1 quarter. The position peaked at $5.65M in Q4 2020. 365 funds tracked by Wall St. Rank hold IONS as of Q1 2021.

  • Graticule Asia Macro Advisors reported no remaining Ionis Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 100,000 Ionis Pharmaceuticals shares in Q1 2021, an estimated $5.65M.
  • Graticule Asia Macro Advisors first reported a position in Ionis Pharmaceuticals in Q4 2020 and held it in 1 quarter.
  • Graticule Asia Macro Advisors's Ionis Pharmaceuticals position peaked at $5.65M in Q4 2020.
  • 365 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2021.

Based on Graticule Asia Macro Advisors's 13F filing for Q1 2021, filed 17 May 2021.